Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer

about

Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer

Item

http://www.wikidata.org/entity/Q59136140

description

scientific article published on 13 November 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@en

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@nl

type

Item

label

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@en

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@nl

prefLabel

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@en

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@nl

P1476

Targeting myeloid-inflamed tum ...... ine model of pancreatic cancer

@en

P2093

Ding Ding

http://www.w3.org/2001/XMLSchema#string

Lisa Coussens

http://www.w3.org/2001/XMLSchema#string

May Tun Saung

http://www.w3.org/2001/XMLSchema#string

Stephen Muth

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory networks and immune surveillance of pancreatic carcinoma

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.

P2888

s40425-018-0435-6

P304

118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40425-018-0435-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1109887636

http://www.w3.org/2001/XMLSchema#string

P698

30424804

http://www.w3.org/2001/XMLSchema#string

P921

immunology

molecular medicine

P932

6234697

http://www.w3.org/2001/XMLSchema#string